06Sep 2023
UK Regulatory Approved Updated Pfizer-BioNTech COVID Vaccine

UK Regulatory Approved Updated Pfizer-BioNTech COVID Vaccine

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has granted approval for an updated COVID-19 vaccine developed by Pfizer and BioNTech, explicitly targeting the Omicron XBB.1.5 subvariant. This vaccine, marketed as Comirnaty, is now authorized for individuals aged 6 months and above. Following European regulatory clearance, the MHRA's decision aligns with efforts by Moderna and Novavax to create monovalent versions for the XBB.1.5 subvariant. The U.S. plans to deploy all three vaccines in the upcoming fall. XBB.1.5, a prominent global variant earlier this year, is now the primary target for coronavirus vaccines, as chosen by regulatory bodies including the FDA.

  • #family health

Like

Save

Share